Literature DB >> 12673733

Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma.

Mei-Chun Cheung1, Agnes S Chan, Stephen C Law, John H Chan, Vincent K Tse.   

Abstract

BACKGROUND: Cognitive dysfunction is common in patients who develop radionecrosis after receiving radiotherapy for nasopharyngeal carcinoma (NPC). However, the impact of the location and volume of radionecrosis on cognitive dysfunction remains unclear. The authors found a significant association between the severity of cognitive impairment and the volume of radionecrosis; in turn, the volume of radionecrosis was affected by patient age at time radiotherapy was completed.
METHODS: Fifty patients with NPC who received radiotherapy were evaluated by a battery of neuropsychologic tests of cognitive function. The brain lesion volume was quantified, and the lesion locations were identified by standardized brain templates. The results of the neuropsychologic tests were correlated with lesion volume. Gender, education, age at the completion of radiotherapy, brain volume, total dose, and fractional dose were evaluated as risk factors for lesion volume.
RESULTS: Lesion volume was correlated significantly with the severity of cognitive deficits. Larger left-hemisphere lesions were correlated with lower verbal memory (from P < 0.001 to P = 0.008) and language abilities (from P = 0.001 to P = 0.018), whereas larger right-hemisphere lesions were associated with worse visual memory (from P = 0.009 to P = 0.039). Finally, patients who received radiotherapy at a younger age had smaller lesion volumes (P < 0.001).
CONCLUSIONS: The volume and location of radionecrosis had an influential impact on the pattern of cognitive impairment found in patients with NPC, and patient age at the time radiotherapy was completed appeared to affect the volume of radionecrosis found after radiotherapy. Copyright 2003 American Cancer Society.

Entities:  

Mesh:

Year:  2003        PMID: 12673733     DOI: 10.1002/cncr.11295

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  28 in total

1.  An analysis of radiation necrosis of the central nervous system treated with bevacizumab.

Authors:  Karen Tye; Herbert H Engelhard; Konstantin V Slavin; M Kelly Nicholas; Steven J Chmura; Young Kwok; Dominic S Ho; Ralph R Weichselbaum; Matthew Koshy
Journal:  J Neurooncol       Date:  2014-02-07       Impact factor: 4.130

2.  Radiation-induced brain structural and functional abnormalities in presymptomatic phase and outcome prediction.

Authors:  Zhongxiang Ding; Han Zhang; Xiao-Fei Lv; Fei Xie; Lizhi Liu; Shijun Qiu; Li Li; Dinggang Shen
Journal:  Hum Brain Mapp       Date:  2017-10-23       Impact factor: 5.038

3.  Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system.

Authors:  Victor A Levin; Luc Bidaut; Ping Hou; Ashok J Kumar; Jeffrey S Wefel; B Nebiyou Bekele; Jai Grewal; Sujit Prabhu; Monica Loghin; Mark R Gilbert; Edward F Jackson
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-04-01       Impact factor: 7.038

Review 4.  Bevacizumab as a treatment option for radiation-induced cerebral necrosis.

Authors:  Christiane Matuschek; Edwin Bölke; Jens Nawatny; Thomas K Hoffmann; Matthias Peiper; Klaus Orth; Peter Arne Gerber; Ethelyn Rusnak; Guido Lammering; Wilfried Budach
Journal:  Strahlenther Onkol       Date:  2011-01-24       Impact factor: 3.621

5.  Oligodendroglioma confers higher risk of radiation necrosis.

Authors:  Haroon Ahmad; David Martin; Sohil H Patel; Joseph Donahue; Beatriz Lopes; Benjamin Purow; David Schiff; Camilo E Fadul
Journal:  J Neurooncol       Date:  2019-09-23       Impact factor: 4.130

6.  Cognitive function and patient-reported memory problems after radiotherapy for cancers at the skull base: A cross-sectional survivorship study using the Telephone Interview for Cognitive Status and the MD Anderson Symptom Inventory-Head and Neck Module.

Authors:  Chase C Hansen; Joshua B Smith; Abdallah S R Mohamed; Collin F Mulcahy; Jeffrey S Wefel; Katherine A Hutcheson; Kelsey Chrane; Jack Phan; Steven J Frank; Adam S Garden; Blaine D Smith; Hillary Eichelberger; Carthal Anderson; Colton McCoy; Marina Horiates; Conner Patrick; Sarah Floris; Chloe French; Beth M Beadle; William H Morrison; Shirley Y Su; Carol M Lewis; Michael E Kupferman; Jason M Johnson; Heath D Skinner; Stephen Y Lai; Ehab Y Hanna; David I Rosenthal; Clifton D Fuller; G Brandon Gunn
Journal:  Head Neck       Date:  2017-08-01       Impact factor: 3.147

7.  Psychological disorders, cognitive dysfunction and quality of life in nasopharyngeal carcinoma patients with radiation-induced brain injury.

Authors:  Yamei Tang; Donghua Luo; Xiaoming Rong; Xiaolei Shi; Ying Peng
Journal:  PLoS One       Date:  2012-06-11       Impact factor: 3.240

8.  Baseline Cognition Assessment Among Patients With Oropharyngeal Cancer Using PROMIS and NIH Toolbox.

Authors:  Parul Sinha; Alex W K Wong; Dorina Kallogjeri; Jay F Piccirillo
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-11-01       Impact factor: 6.223

9.  The Hippocampus: A New Organ at Risk for Postoperative Radiation Therapy for Bucco-alveolar Cancer? A Dosimetric and Biological Analysis.

Authors:  Sapna Nangia; Maneesh Singh; Robin Khosa; Sanjay Kumar Rout; Grishma Singh; Saji Oomen
Journal:  Adv Radiat Oncol       Date:  2021-03-04

10.  Analysis of dosimetric factors associated with temporal lobe necrosis (TLN) in patients with nasopharyngeal carcinoma (NPC) after intensity modulated radiotherapy.

Authors:  Sheng-Fa Su; Shao-Ming Huang; Fei Han; Ying Huang; Chun-Yan Chen; Wei-Wei Xiao; Xue-Ming Sun; Tai-Xiang Lu
Journal:  Radiat Oncol       Date:  2013-01-22       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.